Dec 23 (Reuters) - The U.S. government has paused the distribution of COVID-19 antibody treatments from Regeneron Pharmaceuticals (REGN.O) and Eli Lilly (LLY.N), saying the therapies were unlikely to be effective against the Omicron coronavirus variant.
Dec 28 - Previously the CDC had estimated that as many as 73.2% of coronavirus cases nationwide were due to the Omicron variant on Dec. 18. The new estimate dials it down to 22.5% for the same date.
Oopsie, that'll put some bodies in the Brandon column